Thromboprophylaxis with apixaban and the risk of pulmonary embolism in patients undergoing knee replacement surgery

about

The role of new oral anticoagulants in orthopaedics: an update of recent evidence.

P2860

Q39185541-2EAABF91-59AF-4198-BEB8-A999F20164B5

P2860

Thromboprophylaxis with apixaban and the risk of pulmonary embolism in patients undergoing knee replacement surgery

Item

http://www.wikidata.org/entity/Q36021499

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Thromboprophylaxis with apixab ...... going knee replacement surgery

@ast

Thromboprophylaxis with apixab ...... going knee replacement surgery

@en

type

Item

label

Thromboprophylaxis with apixab ...... going knee replacement surgery

@ast

Thromboprophylaxis with apixab ...... going knee replacement surgery

@en

prefLabel

Thromboprophylaxis with apixab ...... going knee replacement surgery

@ast

Thromboprophylaxis with apixab ...... going knee replacement surgery

@en

P1476

Thromboprophylaxis with apixab ...... going knee replacement surgery

@en

P2093

Anil Pandit

http://www.w3.org/2001/XMLSchema#string

Fadi E Shamoun

http://www.w3.org/2001/XMLSchema#string

Madan Raj Aryal

http://www.w3.org/2001/XMLSchema#string

Ranjan Pathak

http://www.w3.org/2001/XMLSchema#string

Sushil Ghimire

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Apixaban or enoxaparin for thromboprophylaxis after knee replacement.

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.

Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.

Apixaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.

Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa.

Investment in prolonged thromboprophylaxis with dalteparin improves clinical outcomes after hip replacement.

P304

27889

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3402/JCHIMP.V5.27889

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dilli Ram Poudel

Paras Karmacharya

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281516140

http://www.w3.org/2001/XMLSchema#string

P698

26333856

http://www.w3.org/2001/XMLSchema#string

P932

4558285

http://www.w3.org/2001/XMLSchema#string

Thromboprophylaxis with apixaban and the risk of pulmonary embolism in patients undergoing knee replacement surgery

about

P2860

P2860

Thromboprophylaxis with apixaban and the risk of pulmonary embolism in patients undergoing knee replacement surgery

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932